GW Pharma (GWPH) Posts Q1 Loss of 9c/Share

GW Pharma (NASDAQ: GWPH) reported Q2 EPS of ($0.09), $1.48 better than the analyst estimate of ($1.57). Revenue for the quarter came in at $3.81 million versus the consensus estimate of $5.99 million.

For earnings history and earnings-related data on GW Pharma (GWPH) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Edible Garden AG (EDBL) Reports Q2 Loss of $18.79
• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c